BGI Genomics plans to buy back company shares worth 250-500 million yuan.

Announcement from BGI Genomics: it is planned to use its own funds and self-raised funds to repurchase some of the company's issued RMB ordinary shares through centralized bidding trading, with a repurchase price not exceeding RMB 50 per share, and a total repurchase amount of no less than RMB 250 million and no more than RMB 500 million.